Economic Analysis Denosumab v Zoledronic Acid in Multiple Myeloma - 102231

Spotlight
Video

Economic Analysis Denosumab v Zoledronic Acid in Multiple Myeloma

Loading........
Description: Noopur Raje, MD of Massachusetts General Hospital Cancer Center discusses her findings in which Denosumab is favored in newly diagnosed multiple myeloma patients from a recent economic analysis of Denosumab v Zoledronic Acid in Multiple Myeloma at the 2017 Lymphoma and Myeloma meeting in New York.
Shared By : Lymphoma-Myeloma-Conference
Posted on : 11/06/17
Added : 1 year ago
Category : Multiple Myeloma